Masimo
PrivateGlobal medical technology company that develops noninvasive patient monitoring technologies, including Signal Extraction Technology (SET) pulse oximetry. Innovations address limitations in traditional pulse oximetry by providing accurate readings through patient motion and low perfusion. Products used in hospitals worldwide.
Founders Joe Kiani, Mohamed Diab
CEO Joe Kiani
Company
Founded
1989
Headquarters
Irvine, US
Financials
Total Funding
$203M
Sectors
Funding History
1 round Undisclosed Aug 8, 2007
$203M Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.